SCT

SCTherapeutics aims to develop a cell based therapy for the treatment of diabetes. As part of this goal, the Company is developing a process for efficiently directing differentiation of cells to the desired cell type (insulin secreting pancreatic beta cells) and otherwise enriching for the appropriate cell population for transplantation